Gait and Bone Health in SMA
Recruiting
Observational Study
Spinal Muscular Atrophy Type 3
Ambulatory Spinal Muscular Atrophy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 8 – 50
- Sex
- Any
- Study type
- Observational
- Participants needed
- 22 (estimated)
- Sponsor
- Jacqueline Montes · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We hypothesize that gait parameters are associated with BMD and can determine fracture risk in pwSMA. This is an observational study that involves one in-clinic visit (approximately 3 hours) with remote follow-up visits (approximately 15 minute…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Confirmed diagnosis of 5qSMA
* Between 8 and 50 years of age
* Able to walk 10 meters without support or an assistive device
* All participants who meet the inclusion criteria regardless of treatment status will be included, including those on adjuvant therapies, whether inves…
Contacts